Abstract
Purpose: The immune checkpoint inhibitors (ICPIs) comprise a class of oncologic immunotherapies. The most recent US Food and Drug Administration-appro......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
